DOI: http://dx.doi.org/10.18203/issn.2454-5929.ijohns20173086

Clinico-etiopathological and management profile of laryngeal tumours in a tertiary care centre

Pooja Pal, Arvinder Singh Sood, Lavneesh Manchanda, Bikramjit Singh

Abstract


Background: Laryngeal tumours may be neoplastic or non-neoplastic. Our study aimed to analyze the incidence, clinico-etiopathological and management profile of laryngeal tumours.

Methods: This prospective study was performed on 90 cases of laryngeal tumours in the Department of Otolaryngology in a tertiary care hospital from Jan 2015 to June 2016. A detailed clinical history was taken, head & neck examination done, and supplemented with necessary imaging when required. The data thus obtained was recorded and statistically analyzed.  

Results: The ratio of benign to malignant tumours was 1:4. Of the benign tumours, 59% were vocal nodules. They were most common in the third decade (23.5%) and presented with hoarseness. Most patients were housewives (29%) and were associated with vocal abuse. All cases were managed surgically. Ninety seven percent of malignant tumours were squamous cell carcinoma, and seen in the seventh decade (37%). Forty one percent were labourers, and smoking, alcohol and laryngopharyngeal reflux were the predominant risk factors. The supraglottis was the commonest site involved, and dysphagia was the predominant presenting symptom. Majority of patients (42.5%) presented with stage IV disease. Malignant tumours were treated with radiotherapy (55%), chemoradiation (44%) and surgery (1%).

Conclusions: Vocal nodule is the commonest benign tumour of the larynx and presents with hoarseness. The supraglottis is the main subsite to be involved in laryngeal cancer, and presents with dysphagia. Most patients present with stage IV disease. Laryngopharyngeal reflux is an important risk factor for carcinoma larynx.


Keywords


Larynx, Laryngeal tumours, Laryngopharyngeal reflux

Full Text:

PDF

References


Kapil U, Singh P, Bahadur S, Dwivedi SN, Singh R. Assessment of risk factors in laryngeal cancer in India: a case control study. Asian Pac J Cancer Prev. 2005;6:202-7.

Flanders WD, Rothman KJ. Interaction of alcohol and tobacco in laryngeal cancer. Am J Epidemiol 1982;115(3):371-9.

Sellars SL. Benign tumours of the larynx. South Afr Med J. 1979;56(22):943–6.

Bobdey S, Jain A, Balasubramanium G. Epidemiological review of laryngeal cancer:An Indian perspective. Indian J Med Paediatr Oncol. 2015;36(3):154–60.

Goiato MC, Fernandes AUR. Risk factors of laryngeal cancer in patients attended in the oral oncology centre of Aracatuba. Braz J Oral Sci. 2005;4(13):741-4.

Elwood JM, Pearson JC, Skippen DH, Jackson SM. Alcohol, smoking, social and occupational factors in the aetiology of cancer of the oral cavity, pharynx and larynx. Int J Cancer. 1984;34(5):603–12.

Dosemeci M, Gokmen I, Unsal M, Hayes RB, Blair A. Tobacco, alcohol use, and risks of laryngeal and lung cancer by subsite and histologic type in Turkey. Cancer Causes Control. 1997;8(5):729–37.

Bakshi J, Panda NK, Sharma S, Gupta AK, Mann SBS. Survival patterns in treated cases of carcinoma larynx in North India: a 10 years follow up study. Ind J Otolaryngol Head Neck Surg. 2004;56(2):99–103.

Copper MP, Smit CF, Stanojcic LD, Devriese PP, Schouwenburg PF, Mathus-Vilegan LMH. High incidence of laryngopharyngeal reflux in patients with head and neck cancer. Laryngoscope. 2000;110:1007-11.

Galli J, Cammarota G, Calo L, Agostino S, D'Ugo D, Cianci R, et al. The role of acid and alkaline reflux in laryngeal squamous cell carcinoma. Laryngoscope 2002;112:1861-5.

Jaiswal VR, Hoang MP. Primary combined squamous and small cell carcinoma of the larynx. Arch Pathol Lab Med. 2004;128:1279–81.

Mendenhall WM, Dagan R, Bryant CM, Amdur RJ, Mancuso AA. Definitive radiotherapy for squamous cell carcinoma of the glottic larynx. Cancer Control. 2016;23(3):208–12.

Rübe C, Micke O, Grevers G, Rohloff R, Kaufmann H, Busch M, et al. Primary radiotherapy of laryngeal carcinoma. An analysis of the therapeutic results and of the the relapse behavior in 283 patients. Strahlenther Onkol. 1997;173(2):83-90.